Endometrics

Endometrics is a private, pre-revenue diagnostics company founded in 2017 and based in San Diego. It is developing a first-of-its-kind, non-invasive diagnostic test for endometriosis that utilizes menstrual blood and proprietary biomarkers, validated on hundreds of clinical samples. The company has gained significant recognition, winning top awards from the NIH and PMWC, and is led by a founder with deep clinical and research expertise in gynecology. Its goal is to transform the standard of care for a condition affecting 1 in 10 women by enabling earlier, surgery-free diagnosis.

Proprietary molecular biomarker(s) detected in menstrual blood (menstrual effluent) for the non-invasive diagnosis of endometriosis, potentially enhanced by machine learning algorithms.

The competitive landscape includes other biotech and diagnostic companies researching non-invasive methods for endometriosis (e.g., via blood biomarkers, genomic tests). Endometrics differentiates by using menstrual blood and has gained early validation through prestigious awards. The primary competitor remains the entrenched standard of laparoscopic surgery.